Pfizer testing lower doses of its COVID-19 vaccine in children under 12

Pfizer will test its COVID-19 vaccine in a larger group of children between 6 months and 12 years old after choosing a lower dose than it administered in an earlier stage of the trial, The New York Times reported June 8.